Get Full Government Meeting Transcripts, Videos, & Alerts Forever!
Get email alerts on the Opioid Prescribing HB127 topic
No spam. Unsubscribe anytime.
Senate advances substitute of House Bill 127 to let regulators screen prescribers’ opioid patterns
Summary
Senators substituted and passed language in House Bill 127 directing the division to review the controlled-substance database for prescribers whose opioid prescribing patterns fall outside CDC, state health, or literature-based standards; sponsors said the change targets prescribers rather than law-enforcement access to the database.
The Utah Senate on March 7 adopted a substitute to House Bill 127, amending the Controlled Substance Database Act to require the division to review prescribers whose opioid-prescribing patterns appear inconsistent with standards set by the Centers for Disease Control and Prevention, the Utah Department of Health, or relevant medical literature.
Senator Bramble and other supporters said the substitute incorporates the noncontroversial, clinical-review portion of a prior House bill. "The language on the second substitute ... says the division shall review the database to identify any prescriber who has a pattern of prescribing opioids not in accordance with standards established by the CDC or the Department of Health or literature, as reviewed by the medical board," Bramble said.
Supporters including Senator Weiler and Senator Andrew praised the change as a way to focus enforcement and oversight on prescribing behavior rather than expanding law-enforcement access. Senator Vickers asked about fiscal impacts; the sponsor said the House prioritized funding and that the fiscal note had been funded and would shift to the substituted measure.
A roll-call recorded the second substitute’s passage and the clerk announced the bill will be transmitted to the House for further consideration.
